UPDATE: IFS Securities Upgrades Rexahn Pharmaceuticals Inc. (RNN) to Strong Buy
Tweet Send to a Friend
(Updated - October 4, 2018 10:41 AM EDT)
(Updated to add analyst comment, clinical trial safety study details, CEO/CMO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(Updated to add analyst comment, clinical trial safety study details, CEO/CMO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
